# DSTN

## Overview
The DSTN gene encodes destrin, a protein that belongs to the actin-depolymerizing factor (ADF)/cofilin superfamily, which is integral to the regulation of actin filament dynamics. Destrin functions as an actin depolymerizing factor, facilitating the disassembly and severing of actin filaments, a process essential for cellular activities such as migration, cytokinesis, and maintenance of cell shape (Klose2012The; Miano2007Serum). The protein is characterized by the presence of an actin-depolymerizing factor homology (ADF-H) domain, which is crucial for its interaction with actin. Destrin's activity is modulated by post-translational modifications, including phosphorylation, which can inhibit its binding to actin (Shishkin2016Cofilin1). The gene and its encoded protein are implicated in various physiological and pathological processes, including cancer progression and corneal diseases, highlighting its clinical significance (Klose2012The; Verdoni2010A).

## Structure
Destrin, encoded by the DSTN gene, is a member of the actin-depolymerizing factor (ADF)/cofilin superfamily, which plays a crucial role in actin filament dynamics. The primary structure of destrin consists of a sequence of amino acids forming the actin-depolymerizing factor homology (ADF-H) domain, which is essential for its function in actin binding and depolymerization (Shishkin2016Cofilin1). The secondary structure of destrin includes alpha helices and beta sheets, with the ADF-H domain forming specific three-dimensional structures characterized by six-stranded mixed β-sheets (Shishkin2016Cofilin1).

Destrin functions as a monomer and lacks a quaternary structure. Its activity is regulated by post-translational modifications, such as phosphorylation, which can inhibit its binding to actin (Shishkin2016Cofilin1). Destrin contains nuclear localization sequences, allowing it to participate in nuclear transport processes (Shishkin2016Cofilin1). The protein can also interact with phosphatidylinositol 4,5-bisphosphate (PIP2) and serine/threonine-protein kinase LIMK1, which are involved in its regulatory mechanisms (Shishkin2016Cofilin1). The presence of splice variant isoforms has not been specifically detailed in the provided context.

## Function
Destrin (DSTN) is a critical protein involved in the regulation of actin filament dynamics within healthy human cells. It functions primarily as an actin depolymerizing factor, facilitating the disassembly and severing of actin filaments, which is essential for maintaining the dynamic remodeling of the actin cytoskeleton. This process is crucial for various cellular functions, including cell migration, cytokinesis, and maintaining cell shape (Klose2012The; Miano2007Serum).

Destrin increases the dissociation constant of ADP-actin at the pointed end of actin filaments, enhancing the turnover of actin filaments and increasing the pool of ADP-actin available for sequestration by profilin 1 (PFN1). This activity is vital for the rapid turnover of the actin filament network, which is necessary for processes such as cell motility and tissue development (Xu2014Effects; Miano2007Serum).

In the cellular context, destrin is active in the cytoplasm, where it regulates actin dynamics. Its activity is negatively regulated by LIM kinase-mediated phosphorylation, which can lead to its degradation. This regulation is part of a broader signaling pathway involving RhoA and serum response factor (SRF) that modulates actin dynamics (Miano2007Serum).

## Clinical Significance
Mutations and alterations in the DSTN gene, which encodes destrin, an actin-depolymerizing factor, have been implicated in various diseases. In corneal diseases, mutations in DSTN, such as those observed in Dstn corn1 mice, lead to corneal abnormalities including epithelial hyperproliferation, inflammation, and neovascularization. These conditions are linked to the upregulation of the serum response factor (SRF) and its target genes, suggesting that DSTN is genetically upstream of SRF. The conditional ablation of SRF in the corneal epithelium can rescue these phenotypes, indicating a pathogenic relationship between DSTN and SRF in corneal disease (Verdoni2010A).

In pancreatic cancer, DSTN is associated with perineural invasion, a key feature of pancreatic ductal adenocarcinoma. Increased expression of destrin in pancreatic cancer cells enhances their invasiveness, migration, and proliferation, suggesting a role in cancer progression (Klose2012The).

In rectal cancer, DSTN hypomethylation is linked to radiotherapy resistance. DSTN overexpression activates the Wnt/β-catenin signaling pathway, promoting resistance to treatment. This suggests that DSTN could be a target for improving radiotherapy sensitivity in rectal cancer (Wen2022DSTN).

## Interactions
Destrin (DSTN) is known to interact with various proteins, playing a significant role in actin cytoskeleton dynamics. In human keratinocytes, DSTN interacts with Interleukin-38 (IL-38), a member of the IL-1 family of cytokines. This interaction was confirmed through co-immunoprecipitation and proximity ligation assays, indicating a close molecular proximity between IL-38 and DSTN. The interaction was further supported by a yeast two-hybrid screen, which identified DSTN as a prominent binding partner of IL-38, suggesting a role in actin cytoskeleton dynamics in keratinocytes (TalabotAyer2019Interleukin38).

In the context of pancreatic cancer, DSTN is associated with perineural invasion and is upregulated in highly nerve-invasive pancreatic cancer cell clones. Although specific physical interactions with other proteins or nucleic acids in this context are not detailed, the upregulation of DSTN suggests its involvement in cancer cell migration and invasion, potentially through its role in actin filament dynamics (Klose2012The). These interactions highlight the importance of DSTN in both normal cellular processes and pathological conditions.


## References


[1. (TalabotAyer2019Interleukin38) Dominique Talabot-Ayer, Loïc Mermoud, Julia Borowczyk, Justyna Drukala, Michal Wolnicki, Ali Modarressi, Wolf-Henning Boehncke, Nicolo Brembilla, and Gaby Palmer. Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes. PLOS ONE, 14(11):e0225782, November 2019. URL: http://dx.doi.org/10.1371/journal.pone.0225782, doi:10.1371/journal.pone.0225782. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0225782)

[2. (Xu2014Effects) J.N. Xu, X. Liu, H. Wang, C.M. Hu, Q.H. Luo, and Q.Q. Zhou. Effects of destrin pathway mutations on the gene expression profile. Genetics and Molecular Research, 13(2):2628–2637, 2014. URL: http://dx.doi.org/10.4238/2014.april.8.5, doi:10.4238/2014.april.8.5. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.4238/2014.april.8.5)

3. (Wen2022DSTN) DSTN hypomethylation promotes radiotherapy resistance of rectal cancer by activating Wnt/β-catenin signaling pathway. This article has 0 citations.

[4. (Miano2007Serum) Joseph M. Miano, Xiaochun Long, and Keigi Fujiwara. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. American Journal of Physiology-Cell Physiology, 292(1):C70–C81, January 2007. URL: http://dx.doi.org/10.1152/ajpcell.00386.2006, doi:10.1152/ajpcell.00386.2006. This article has 393 citations.](https://doi.org/10.1152/ajpcell.00386.2006)

[5. (Klose2012The) Theresa Klose, Ivane Abiatari, Tamar Samkharadze, Tiago De Oliveira, Carsten Jäger, Merab Kiladze, Nataliya Valkovskaya, Helmut Friess, Christoph W. Michalski, and Jörg Kleeff. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer. Pancreatology, 12(4):350–357, July 2012. URL: http://dx.doi.org/10.1016/j.pan.2012.05.012, doi:10.1016/j.pan.2012.05.012. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pan.2012.05.012)

[6. (Verdoni2010A) Angela M Verdoni, Keaton J Schuster, Brian S Cole, Akihiro Ikeda, Winston W Kao, and Sakae Ikeda. A pathogenic relationship between a regulator of the actin cytoskeleton and serum response factor. Genetics, 186(1):147–157, September 2010. URL: http://dx.doi.org/10.1534/genetics.110.117309, doi:10.1534/genetics.110.117309. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1534/genetics.110.117309)

[7. (Shishkin2016Cofilin1) Sergey Shishkin, Lidia Eremina, Natalya Pashintseva, Leonid Kovalev, and Marina Kovaleva. Cofilin-1 and other adf/cofilin superfamily members in human malignant cells. International Journal of Molecular Sciences, 18(1):10, December 2016. URL: http://dx.doi.org/10.3390/ijms18010010, doi:10.3390/ijms18010010. This article has 62 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18010010)